SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

J.B.Chemicals & Pharmaceuticals informs about analyst meet

27 Jan 2022 Evaluate
J.B.Chemicals & Pharmaceuticals has informed that the Company has scheduled a conference call for investors and analysts on Thursday, January 27, 2022 at 3.30 pm IST to discuss the Acquisition of Brands and Related Assets from Sanzyme.

The above information is a part of company’s filings submitted to BSE.

JB Chem & Pharma Share Price

2187.40 -8.55 (-0.39%)
18-Jun-2026 14:08 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1823.50
Dr. Reddys Lab 1265.80
Cipla 1351.35
Zydus Lifesciences 1071.70
Lupin 2312.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: